Skip to content

Clinical trials

Withdrawn Phase 2 Respiratory Distress Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 2 Status: Withdrawn Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20143
20181
20191
20202
20213
20221
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Exvastat Ltd.1
Hope Pharmaceuticals1
ImmunityBio, Inc.1
Implicit Bioscience1
King Abdullah International Medical Research Center1
Mallinckrodt1
National Taiwan University Hospital1
Sciwind Biosciences APAC CO Pty. Ltd.1
Sorrento Therapeutics, Inc.1
Universidade Federal do Rio de Janeiro1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome14
COVID-194
Acute Lung Injury3
Sepsis2
Acute Kidney Injury1
Community-Acquired Pneumonia1
Hyaline Membrane Disease1
Lymphopenia1
Pulmonary Edema1
Respiratory Insufficiency1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.